Game Changer: TAVR May Be Safer Than Surgery
3 min readMar 18, 2019
PARTNERS -3 and Evolute trials may change they way we treat aortic stenosis
It is a potential game-changer.
Two studies were released during the annual meeting of the American College of Cardiology today. They are the PARTNER-3 and Evolut trials, comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR).
